Fetal and neonatal thyroid function in relation to maternal Graves' disease

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 18, Issue 2, 2004, Pages 289-302

  Polak, Michel ^a   Le Gac, Isabelle ^a   Vuillard, Edith ^a   Guibourdenche, J ^a   Leger, J ^a   Toubert, M E ^a   Madec, A M ^a   Oury, J F ^a   Czernicchow, P ^a   Luton, Dominique ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Colour Doppler ultrasonography; Fetal goiter; Graves' disease; Prenatal treatment

Indexed keywords

ANTITHYROID AGENT; BENZYLTHIOURACIL; LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BONE MATURATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; FEMALE; FETUS; FETUS BLOOD; FETUS DISEASE; FETUS HEART RATE; FETUS OUTCOME; GESTATIONAL AGE; GOITER; GRAVES DISEASE; HEART FAILURE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NEWBORN; NEWBORN DISEASE; PRENATAL DIAGNOSIS; RADIOIMMUNOASSAY; SKIN APLASIA; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROIDECTOMY; TRACHEOESOPHAGEAL FISTULA; UMBILICAL CORD BLOOD;

EID: 3042570228     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.03.009     Document Type: Review

References (47)

1. Chopra IJ. Fetal and neonatal hyperthyroïdism. Thyroïd 1992; 2: 161-163.
2. McKenzie JM & Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroïdism due to maternal TSH receptor antibodies. Thyroïd 1992; 2: 155-159.
3. Foley PT. In Bercu BB & Shulman DI (eds) Advances in Perinatal Thyroïdology (Maternally transferred thyroïd disease in the infant: recognition and treatment).; 1991, pp 209-226.
4. Eason E, Costom B & Papageorgiou AN. Hypertension in neonatal thyrotoxicosis. Journal of Pediatrics 1982; 100: 766-768.
5. Polikar R, Burger AG, Scherrer U & Nicod P. The thyroïd and the heart. Circulation 1993; 87: 1435-1441.
6. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. Journal of Clinical Endocrinology and Metabolism 1993; 77: 334-338.
7. Neal PR, Jansen RD, Lemons JA, et al. Unusual manisfestations of neonatal hyperthyroïdism. American Journal of Perinatology 1985; 2: 231-235.
8. Fong TL, McHutchison JG & Reynolds TB. Hyperthyroïdism and hepatic dysfunction: a case series analysis. Journal of Clinical Gastroenterology 1992; 14: 240-244.
9. Bahn RS & Heufelder AE. Pathogenesis of Grave's ophthalmopathy. New England Journal of Medicine 1993; 329: 1468-1475.
10. Léger J & Czernichow P. Métabolisme phosphocalcique normal et pathologique chez l'enfant (Troubles du métabolisme phosphocalcique et osseux au cours des affections thyroïdiennes). Flammarion Médecine Science 1993; : 131-136.
11. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroïdism and congenital malformation in the offspring. Clinical Endocrinology 1984; 20: 695-700.
12. Daneman D & Howard NJ. Neonatal thyrotoxicosis: Intellectual impairment and craniosynostosis in later years. Journal of Pediatrics 1980; 97: 257-259.
13. Kopelman AE. Delayed cerebral development in twins with congenital hyperthyroïdism. American Journal of Disease in Childhood 1983; 137: 842-845.
14. Hollingsworth DR & Mabry CC. Congenital Graves' disease: Four familial cases with longterm followup and perspective. American Journal of Disease in Childhood 1976; 130: 148-155.
15. Yoshimoto M, Nakayama M & Baba T. A case of neonatal McCuneAlbright syndrome with Cushing syndrome and hyperthyroïdism. Acta Paediatrica Scandinavia 1991; 80: 984-987.
16. Kopp P, Van Sande J, Parma J, et al. Brief report: Congenital hyperthyroïdism caused by a mutation in the thyrotropin receptor gene. New England Journal of Medicine 1995; 332: 150154.
17. Lefkowitz RJ. G proteins in medicine. New England Journal of Medicine 1995; 332: 186187.
18. De Roux N, Polak M, Couet J, et al. A neomutation of the TSH receptor in a severe neonatal hyperhtyroidism. Journal of Clinical Endocrinology and Metabolism 1996; 81: 2023-2026.
19. Polak M, Leger J, Luton D, et al. Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroïdism in the offsprings of a euthyroïd mother, producing thyroïd stimulating immunoglobulins. Annales d'Endocrinologie 1997; 4: 348-352.
20. Polak M. Activating mutations of the thyrotropin receptor: a short review with emphasis on some pediatric aspects. European Journal of Endocrinology 1998; 138: 353-357.
21. Polak M, Leger J & Czernichow P. Journées Parisiennes de Pédiatrie (Les hyperthyroïdies du nouveau-né). Flammarion Médecine-Sciences 1995; : 249-257.
22. Fischer DA. Endocrinology of fetal development. In Wilson JD & Foster DW (eds) Textbook of endocrinology. Philadelphia: WB Saunders, 1999, pp 2073-2102.
23. Polak M. Hyperthyroïdies foetales: mécanismes, explorations, traitement et conséquences pour l'enfant. Reproduction Humaine et Hormones 2001; 10: 683-689.
24. Vassart G & Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrine Reviews 1992; 3: 596-611.
25. Burrow GN, Fisher DA & Larsen PR. Maternal and fetal thyroïd function. New England Journal of Medicine 1994; 331: 1072-1078.
26. Zakarija M & McKenzie JM. Pregnancyassociated changes in the thyroïdstimulating antibody of Grave's disease and the relationship to neonatal hyperthyroïdism. Journal of Clinical Endocrinology and Metabolism 1983; 57: 1036-1041.
27. Ranzini AC, Ananth CV, Smulian JC, et al. Ultrasonography of the featl thyroid: normograms based on biparietal diameter and gestational age. Journal of Ultrasound in Medicine 2001; 20: 613-617.
28. Porreco RP & Bloch CA. Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstetrics and Gynecology 1990; 76: 509-512.
29. Bruinse HW, VermeulenMeiners C & Wit JM. Fetal treatment for thyrotoxicosis in nonthyrotoxic pregnant women. Fetal Therapy 1988; 3: 152-157.
30. Momotani N, Noh JY, Ishikawa IN & Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1997; 82: 3633-3636.
31. Bricaire H, Viron B, Czernichow P & Luton JP. Traitements par antithyroïdiens de synthèse au cours de la grossesse. La presse médicale 1983; 17: 1057-1062.
32. Matsuura N, Konishi J, Fujieda K, et al. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring. Lancet 1988; 2: 14-17.
33. Sagot P, David A, Yvinec M, Pousset P, Papon V, Mouzard A & Boog G. Foetal diagnosis and therapy 1991; 6: 28-33.
34. Volumenie JL, Polak M, Guibourdenche J, et al. Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit. Prenatal diagnosis 2000; 20: 799-806.
35. Weetman AP. Graves' disease. New England Journal of Medicine 2000; 26: 1236-1248.
36. e édition. Paris: Elsevier, 2001, pp 392-399.
37. Luton D, Fried D, Sibony O, et al. Assessment of fetal thyroid function by colored doppler echography. Fetal Diagnosis and Therapy 1997; 12: 24-27.
38. Clavel S, Madec AM, Bornet H, et al. Anti-TSH receptor antibodies in pregnant patients with autoimmune thyroid disorder. British Journal of Obstetrics and Gynaecology 1990; 97: 1003.
39. Guibourdenche J, Noel M, Chevenne D, et al. Biochemical investigation of foetal and neonatal thyroid function using the ACS-180SE analyser: clinical application. Annals of clinical biochemistry 2001; 38: 520-526.
40. Fantz CR, Dagogo-Jack S, Ladenson JH & Gronowski AM. Thyroid function during pregnancy. Clinical Chemistry 1999; 45: 2250-2258.
41. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997; 18: 404-433.
42. Massart C, Orgiazzi J & Maugendre D. Clinical validity of a commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves disease treated with antithyroid drugs. Clinica chimica acta 2001; 304: 39-47.
43. Doroz Ph. Guide Pratique des médicaments. Paris: Maloine, 1995.
44. Daffos F, Capella-Pavlovsky M & Forestier F. Fetal blood sampling during pregnancy ith use of a needle guided by ultrasound: a study of 606 consecutive cases. American Journal of Obstetrics and Gynaecology 1985; 153: 655-656.
45. Nachum Z, Rakover Y, Weiner E & Shalev E. Graves' disease in pregnancy: a prospective evaluation of a selective invasive treatment protocol. American Journal of Obstetrics and Gynaecology 2003; 189: 159-165.
46. Skuza KA, Sills IN, Stene M & Rapaport R. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves' disease. Journal of Pediatrics 1996; 128: 264-267.
47. Polak M. Hyperthyroidism in Early Infancy: Pathogenesis. Clinical Features and Diagnosis strategy with a Focus on Neonatal Hyperthyroïdism. Thyroïd 1998; 12: 1171-1177.